Volume 60, Issue 1, Pages (July 2001)

Slides:

Advertisements

Similar presentations

Evaluation and treatment of coronary artery disease in patients with end-stage renal disease Peter A. McCullough Kidney International Volume 67, Pages.

Advertisements

Improved prognosis of diabetic nephropathy in type 1 diabetes

Steven Fishbane, Jeffrey S. Berns, M.D. Kidney International

Volume 55, Issue 2, Pages (February 1999)

Plasma sodium and hypertension

Frederik Persson, Peter Rossing Kidney International Supplements

Anemia management in chronic kidney disease

Confounding: What it is and how to deal with it

From secondary to primary prevention of progressive renal disease: The case for screening for albuminuria Paul E. De Jong, Barry M. Brenner Kidney International

Volume 61, Issue 4, Pages (April 2002)

Volume 67, Issue 6, Pages (June 2005)

Volume 59, Issue 1, Pages (January 2001)

Membranous nephropathy: When and how to treat

Gudrun Hatlen, Solfrid Romundstad, Stein I. Hallan

Prehypertension and chronic kidney disease: the ox or the plow?

Peter Rossing, Philip Hougaard, Hans-Henrik Parving

‘Progressive diabetic nephropathy. How useful is microalbuminuria

Need for better diabetes treatment for improved renal outcome

Volume 58, Issue 1, Pages (July 2000)

Volume 70, Pages S21-S25 (December 2006)

Volume 55, Issue 2, Pages (February 1999)

Volume 57, Pages S32-S37 (April 2000)

Progression of diabetic nephropathy

Methotrexate in the urine

Volume 54, Issue 4, Pages (October 1998)

Volume 74, Issue 3, Pages (August 2008)

Comparative effects of potassium chloride and bicarbonate on thiazide-induced reduction in urinary calcium excretion Lynda A. Frassetto, Eileen Nash,

The epidemiology of chronic kidney disease

Blood pressure targets in hemodialysis patients

Volume 85, Issue 3, Pages (March 2014)

Volume 67, Issue 1, Pages (January 2005)

Volume 53, Issue 4, Pages (April 1998)

Progression of diabetic nephropathy: Role of plasma homocysteine and plasminogen activator inhibitor-1 Peter Hovind, MD, Lise Tarnow, MD, Peter Rossing,

Volume 69, Issue 12, Pages (June 2006)

Volume 69, Issue 3, Pages (February 2006)

Volume 63, Pages S38-S42 (February 2003)

Proteinuria and hypertensive nephrosclerosis in African Americans

Environmental exposure to lead and progressive diabetic nephropathy in patients with type II diabetes J.-L. Lin, D.-T. Lin-Tan, C.-C. Yu, Y.-J. Li, Y.-Y.

Volume 67, Issue 4, Pages (April 2005)

Volume 67, Pages S52-S54 (January 2005)

Simvastatin in nephrotic syndrome

V.R. Sørensen, P.M. Hansen, J. Heaf, B. Feldt-Rasmussen

Volume 74, Issue 5, Pages (September 2008)

Improved prognosis of diabetic nephropathy in type 1 diabetes

Volume 58, Issue 3, Pages (September 2000)

Yasunori Kitamoto, Katsuhiko Matsuo, Kimio Tomita Kidney International

The course of the remnant kidney model in mice

Current status of maintenance hemodialysis in Beijing, China

Phosphate binders on iron basis: A new perspective?

Organ transplantation goes to the movies

Atherosclerotic nephropathy

Volume 74, Issue 9, Pages (November 2008)

Volume 77, Issue 1, Pages (January 2010)

Volume 72, Issue 11, Pages (December 2007)

Is it the low-protein diet or simply the salt restriction?

Volume 70, Issue 3, Pages (August 2006)

Importance of blood pressure control in hemodialysis patient survival

Volume 70, Issue 5, Pages (September 2006)

Volume 56, Issue 4, Pages (October 1999)

Volume 62, Issue 5, (November 2002)

Volume 68, Issue 3, Pages (September 2005)

Volume 58, Issue 2, Pages (August 2000)

Dana V. Rizk, David G. Warnock Kidney International

The International Pediatric Peritonitis Registry: Starting to walk

Volume 68, Issue 3, Pages (September 2005)

Volume 53, Issue 5, Pages (May 1998)

Volume 58, Issue 5, Pages (November 2000)

Volume 57, Issue 2, Pages (October 2000)

Volume 54, Pages S112-S119 (December 1998)

Volume 79, Issue 10, Pages (May 2011)

Presentation transcript:

Volume 60, Issue 1, Pages 277-283 (July 2001) Remission and regression in the nephropathy of type 1 diabetes when blood pressure is controlled aggressively1 Peter Hovind, M.D., Peter Rossing, Lise Tarnow, Ulla M. Smidt, Hans-Henrik Parving Kidney International Volume 60, Issue 1, Pages 277-283 (July 2001) DOI: 10.1046/j.1523-1755.2001.00797.x Copyright © 2001 International Society of Nephrology Terms and Conditions

Figure 1 Prevalence of remission, defined as urinary albumin excretion rate <200 μg/min that is sustained for at least one year during follow-up, in 301 type 1 diabetic patients with diabetic nephropathy. Symbols are: () no antihypertensive treatment; (□) antihypertensive treatment. Kidney International 2001 60, 277-283DOI: (10.1046/j.1523-1755.2001.00797.x) Copyright © 2001 International Society of Nephrology Terms and Conditions

Figure 2 Prevalence of regression, defined as rate of decline in GFR ≤1 mL/min/year, in 301 type 1 diabetic patients with diabetic nephropathy. Symbols are: () no antihypertensive treatment; (□) antihypertensive treatment. Kidney International 2001 60, 277-283DOI: (10.1046/j.1523-1755.2001.00797.x) Copyright © 2001 International Society of Nephrology Terms and Conditions